RNAi mediated knockdown of NuMA for cancer therapy

Details for Australian Patent Application No. 2008313240 (hide)

Owner Reliance Life Sciences Pvt. Ltd.

Inventors Eswar, Chandra Vidyadhar Reddy Gopavaram; Kriti, Bimalendu Ray; Murali, Krishna Addepalli

Agent Allens Arthur Robinson

Pub. Number AU-A-2008313240

PCT Pub. Number WO2009/050730

Priority 1130/MUM/2007 15.06.07 IN

Filing date 13 June 2008

Wipo publication date 23 April 2009

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2009/050730 Priority application(s): WO2009/050730

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008313248-An orally administerable solid pharmaceutical composition and a process thereof

2008313233-Composite steel claded mill liner